Doctor of Optometry Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Jennifer Luckie

Optometrist Washington, DC Doctor of Optometry

NPI 1942674197 CMS profile 1375801

1016 16Th St Nw Bsmt Ll, Washington, DC 20036

Open in the dashboard

General payments

$2,457

85 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Jennifer Luckie of Washington, DC is reported in the CMS Open Payments database as having received $2,457 across 85 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $597 21
2022 General $393 18
2021 General $729 22
2020 General $198 10
2019 General $539 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Luckie
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Jennifer Luckie were reported at $0. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Jennifer Luckie Optometrist median Middle half National median
2019 $539 $159 $67–$371 $163
2020 $198 $72 $29–$165 $114
2021 $729 $125 $46–$292 $132
2022 $393 $162 $66–$374 $149
2023 $597 $177 $72–$406 $160
2024 $0 $188 $77–$427 $164
2025 $0 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Alcon Vision LLC $348 10 payments
  2. Visionary Optics LLC $320 1 payment
  3. Johnson & Johnson Surgical Vision, Inc. $260 3 payments
  4. Novartis Pharmaceuticals Corporation $232 19 payments
  5. Sun Pharmaceutical Industries Inc. $189 7 payments
  6. Johnson & Johnson Vision Care, Inc. $178 7 payments
  7. Bausch & Lomb, a division of Bausch Health US, LLC $172 4 payments
  8. Allergan Inc. $168 9 payments
  9. CooperVision Inc. $166 4 payments
  10. Oyster Point Pharma, Inc. $156 8 payments
  11. Other $268 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $2,137 84 payments
  2. Gift $320 1 payment
Products named General payments · program years 2019–2023
  1. XIIDRA $232 19 payments
  2. Tecnis IOL $202 2 payments
  3. Cequa $189 7 payments
  4. Acuvue $178 7 payments
  5. Clariti Contact Lens $166 4 payments
  6. TYRVAYA $156 8 payments
  7. DAILIES $142 5 payments
  8. ULTRA $138 2 payments
  9. TOTAL30 $132 1 payment
  10. DAILIES TOTAL1 $132 1 payment
  11. Other $1,427 44 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

85 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record